Platelet Apoptosis in Patients with Coronary Artery Disease Before and After CABG

Arkadiy A Metelkin1, Ekaterina A Sergeeva1, Mikhail A Popov2

  • 1Department of Molecular and Cellular Pathophysiology, Research Institute of General Pathology and Pathophysiology, Baltiyskaya 8, 125315 Moscow, Russia.

Insights

Platelet apoptosis, a process of programmed cell death, changes significantly after coronary artery bypass graft (CABG) surgery. These dynamics in platelet function may help predict cardiovascular disease outcomes and complications.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Cellular Biology

Background:

  • Cardiovascular diseases, including coronary artery disease, are a leading global cause of mortality.
  • Predicting long-term outcomes after coronary artery bypass graft (CABG) surgery remains challenging.
  • Platelet function is integral to cardiovascular disease progression and may predict postoperative complications.

Purpose of the Study:

  • To investigate the changes in platelet apoptosis before and after CABG surgery.
  • To explore the role of platelet apoptosis in coronary artery disease and atherosclerosis.
  • To assess the potential of platelet apoptosis dynamics in predicting postoperative complications.

Main Methods:

  • Flow cytometry, Western blot, and polymerase chain reaction were employed.
  • Evaluation of platelet apoptosis and activation markers.
  • Assessment of platelet membrane changes and mitochondrial membrane depolarization.

Main Results:

  • Significant changes in platelet apoptosis dynamics were observed post-CABG.
  • Evidence of apoptosis activation via an extrinsic receptor-dependent pathway, including caspase 8 and BCL-2 expression.
  • Alterations in platelet membrane and mitochondrial membrane potential were detected.

Conclusions:

  • Platelet apoptosis plays a significant role in the pathophysiology of coronary artery disease and atherosclerosis.
  • Changes in platelet metabolic processes and apoptosis are linked to postoperative complications after CABG.
  • Platelet apoptosis dynamics offer potential as a predictive marker for cardiovascular disease outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.9K
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
616
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
597